Adalimumab in the treatment of arthritis

Tumor necrosis factor (TNF) has been implicated in a number of arthritic disease states, including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Adalimumab is the first fully human, high-affinity, recombinant immunoglobulin G(1) (IgG(1)) anti-TNF monoclonal antibody. Adalimu...

Descripción completa

Detalles Bibliográficos
Autor principal: Mease, Philip J
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936294/
https://www.ncbi.nlm.nih.gov/pubmed/18360621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936294/
https://www.ncbi.nlm.nih.gov/pubmed/18360621

Ejemplares similares